From: A Poisson reduced-rank regression model for association mapping in sequencing data
Factor | Pathway | Adjusted p-val | NES | Leading edge |
---|---|---|---|---|
1 | ALLOGRAFT REJECTION | 7.16e-05 | 1.15e+00 | FLNA,KRT1,RPS3A |
1 | APICAL JUNCTION | 1.13e-03 | 1.13e+00 | ACTB,MYL9,ACTG1 |
1 | EMT | 5.32e-07 | 1.18e+00 | FN1,FLNA,TAGLN |
1 | HYPOXIA | 1.29e-03 | 1.12e+00 | DCN,ANXA2,FOS |
1 | MYC TARGETS V1 | 1.80e-03 | 1.12e+00 | RPLP0,RPS6,RPS2 |
1 | MYOGENESIS | 3.91e-06 | 1.17e+00 | MYH11,TAGLN,GSN |
1 | P53 PATHWAY | 2.61e-03 | 1.12e+00 | PERP,RACK1,TXNIP |
1 | TNFA SIG. VIA NFKB | 6.57e-03 | 1.11e+00 | FOS,DUSP1,CD44 |
7 | APICAL JUNCTION | 1.79e-05 | 1.20e+00 | MYL9,MYH9,ACTB |
7 | APOPTOSIS | 8.01e-06 | 1.23e+00 | DCN,GPX3,GSN |
7 | COAGULATION | 3.60e-07 | 1.27e+00 | A2M,FN1,SPARC |
7 | COMPLEMENT | 3.83e-04 | 1.17e+00 | FN1,CSRP1,CLU |
7 | EMT | 7.22e-12 | 1.29e+00 | ACTA2,TAGLN,FN1 |
7 | HYPOXIA | 2.62e-05 | 1.19e+00 | MYH9,DCN,BGN |
7 | IL2 STAT5 SIGNALING | 7.48e-03 | 1.13e+00 | COL6A1,AHNAK,TGM2 |
7 | MITOTIC SPINDLE | 1.39e-03 | 1.15e+00 | FLNA,MYH9,GSN |
7 | MYC TARGETS V1 | 1.20e-03 | 1.15e+00 | HSP90AB1,RPS6,RPLP0 |
7 | MYOGENESIS | 2.45e-11 | 1.29e+00 | TAGLN,MYH11,COL6A2 |
7 | TNFA SIG. VIA NFKB | 1.39e-03 | 1.15e+00 | NR4A1,RHOB,ZFP36 |
7 | UV RESPONSE DN | 1.91e-03 | 1.17e+00 | COL1A2,IGFBP5,COL3A1 |